Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A framework for cost-effectiveness analysis from clinical trial data.

A O'Hagan1, J W Stevens

  • 1University of Sheffield, UK.

Health Economics
|June 16, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preventing the Progression to Type 2 Diabetes Mellitus in Adults at High Risk: A Systematic Review And Network Meta-Analysis of Lifestyle, Pharmacological and Surgical Interventions.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

The Cost-Effectiveness of Biologic Dmards in Patients With Severe or Mild-To-Severe Rheumatoid Arthritis After Conventional Dmards.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Ledipasvir-Sofosbuvir for Treating Chronic Hepatitis C: A NICE Single Technology Appraisal-An Evidence Review Group Perspective.

PharmacoEconomics·2016
Same author

Systematic review, network meta-analysis and exploratory cost-effectiveness model of randomized trials of minimally invasive techniques versus surgery for varicose veins.

The British journal of surgery·2014
Same author

Authors' reply: systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630-1638).

The British journal of surgery·2013
Same author

Clinical effectiveness and cost-effectiveness of minimally invasive techniques to manage varicose veins: a systematic review and economic evaluation.

Health technology assessment (Winchester, England)·2013
Same journal

Lead in Drinking Water and Child Health: Evidence From Jackson, Mississippi.

Health economics·2026
Same journal

Health on the Move: The Impact of Poverty Alleviation Relocation on Healthcare Utilization in China.

Health economics·2026
Same journal

The Effects of Compulsory Licensing: A Case Study of HIV Drugs.

Health economics·2026
Same journal

Beyond Tobacco Prevention: The Effects of Tobacco 21 Laws on Young Adults' Body Weight.

Health economics·2026
Same journal

Assessing the Estimands and Estimates of Hospitalization Rates in Health Economics and Clinical Medicine.

Health economics·2026
Same journal

The Impact of Unemployment Insurance Benefit Cuts on Mental Health: Evidence From Early Pandemic Program Expirations.

Health economics·2026
See all related articles

This study introduces a flexible Bayesian framework for cost-effectiveness analysis (CEA) using clinical trial data. It enables robust modeling of diverse cost and efficacy outcomes, aiding healthcare decision-making.

Area of Science:

  • Health economics
  • Biostatistics
  • Clinical trial analysis

Background:

  • Cost-effectiveness analysis (CEA) is crucial for healthcare resource allocation.
  • Existing CEA methods often lack flexibility in modeling diverse clinical trial data.
  • Integrating cost and efficacy data from trials presents statistical challenges.

Purpose of the Study:

  • To present a general Bayesian framework for conducting CEA using clinical trial data.
  • To develop a flexible modeling approach accommodating various cost and efficacy outcome types.
  • To establish a unified CEA technique applicable to a wide range of statistical models.

Main Methods:

  • Developed a general Bayesian framework for CEA.
  • Linked mean efficacy and mean cost to model parameters.

Related Experiment Videos

  • Demonstrated flexibility with continuous, binary, ordinal, and time-to-event efficacy outcomes.
  • Modeled costs using normal, log-normal, mixture, and non-parametric distributions.

    • Main Results:

    • The proposed Bayesian framework accommodates flexible modeling of cost and efficacy data.
    • A unified CEA technique is established for a broad class of statistical models.
    • The framework successfully integrates diverse outcome measures and cost distributions.
    • A case study illustrates the methodology and the impact of prior information.

    Conclusions:

    • The Bayesian framework provides a versatile and robust approach to CEA from clinical trial data.
    • This methodology enhances the ability to model complex cost and efficacy relationships.
    • The framework supports informed healthcare decision-making by providing comprehensive economic evaluations.